Access to abortion pill in limbo after competing rulings

Two separate court rulings on the legality of the abortion medication, mifepristone, have caused uncertainty surrounding access to the drug in the US, just a year after Roe v. Wade was overturned. U.S. District Judge Matthew Kacsmaryk overruled the FDA's scientific approval of mifepristone, essentially placing a hold on its availability, while another court in Washington, D.C., led by Judge Thomas O.

Leave a Reply

Your email address will not be published. Required fields are marked *